United Laboratories International (HKG:3933) said Ceftriaxone Sodium for Injection has received approval from China's National Medical Products Administration as having passed the consistency evaluation of quality and efficacy for generic drugs, a Friday filing with the Hong Kong bourse said.
The drug was submitted by the Zhongshan Branch of Zhuhai United Laboratories, a unit of the intermediate and finished products and bulk medicine company.
The drug is an antibiotic for the treatment of infections caused by sensitive pathogens, including respiratory tract, abdominal, renal and urinary tract, reproductive system, and preoperative infections.